IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 10,850
-530 (-4.66%)
Oct 10, 2025, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 152.09 billion as of October 10, 2025. Its market cap has decreased by -36.77% in one year.
Market Cap
152.09B
Enterprise Value
127.85B
Revenue
3.83B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,850.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 152.09B, a decrease of -69.81%. That is a compound annual growth rate of -54.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 152.09B | 1.88% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.17T |
| Celltrion | 38.24T |
| ALTEOGEN | 24.66T |
| Yuhan | 9,028.52B |
| SK Biopharmaceuticals | 8,136.75B |
| Peptron | 6,866.96B |
| PharmaResearch | 5,631.19B |
| LigaChem Biosciences | 5,483.63B |